X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. - Université Paris Cité Accéder directement au contenu
Article Dans Une Revue Orphanet Journal of Rare Diseases Année : 2012

X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management.

Résumé

ABSTRACT: X-linked adrenoleukodystrophy (X-ALD) is the most common peroxisomal disorder. The disease is caused by mutations in the ABCD1 gene that encodes the peroxisomal membrane protein ALDP which is involved in the transmembrane transport of very long-chain fatty acids (VLCFA; >C22). A defect in ALDP results in elevated levels of VLCFA in plasma and tissues. The clinical spectrum in males with X-ALD ranges from isolated adrenocortical insufficiency and slowly progressive myelopathy to devastating cerebral demyelination. The majority of heterozygous females will develop symptoms by the age of 60 years. In individual patients the disease course remains unpredictable. This review focuses on the diagnosis and management of patients with X-ALD and provides a guideline for clinicians that encounter patients with this highly complex disorder.
Fichier principal
Vignette du fichier
1750-1172-7-51.pdf (702.34 Ko) Télécharger le fichier
1750-1172-7-51.xml (104.76 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Format : Autre
Loading...

Dates et versions

inserm-00755770 , version 1 (21-11-2012)

Identifiants

Citer

Marc Engelen, Stephan Kemp, Marianne de Visser, Björn van Geel, Ronald Wanders, et al.. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management.. Orphanet Journal of Rare Diseases, 2012, 7 (1), pp.51. ⟨10.1186/1750-1172-7-51⟩. ⟨inserm-00755770⟩
312 Consultations
360 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More